(Q46345979)

21 December 2017

title

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice (English)

1 reference

21 December 2017

author name string

Tian J

1

1 reference

21 December 2017

Clare-Salzler M

2

1 reference

21 December 2017

Herschenfeld A

3

1 reference

21 December 2017

Middleton B

4

1 reference

21 December 2017

Newman D

5

1 reference

21 December 2017

Mueller R

6

1 reference

21 December 2017

Arita S

7

1 reference

21 December 2017

Evans C

8

1 reference

21 December 2017

Atkinson MA

9

1 reference

21 December 2017

Mullen Y

10

1 reference

21 December 2017

Sarvetnick N

11

1 reference

21 December 2017

Tobin AJ

12

1 reference

21 December 2017

Lehmann PV

13

1 reference

21 December 2017

Kaufman DL

14

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

21 December 2017

published in

Nature Medicine

1 reference

21 December 2017

volume

2

1 reference

21 December 2017

issue

12

1 reference

21 December 2017

page(s)

1348-1353

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/nm1296-1348

exact match

0 references

cites work

Insulin-dependent diabetes mellitus as an autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Prevention of Autoimmune Diabetes in Nonobese Diabetic Female Mice by Treatment with Recombinant Glutamic Acid Decarboxylase (GAD 65)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase (GAD65).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Induction of TH1 and TH2 immunity in neonatal mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Peptide therapy for diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD Mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Maintenance of in vivo tolerance by persistence of antigen

1 reference

https://api.crossref.org/works/10.1038%2FNM1296-1348

7 January 2021

Identifiers

DOI

10.1038/NM1296-1348

1 reference

21 December 2017

1 reference

21 December 2017